Submitted on Wednesday 6th July 2016
Published on Monday 18th July 2016
Current status: Closed
Closed: Wednesday 18th January 2017
Signatures: 5,195
Pressure NICE to approve nivolumab to treat advanced Kidney Cancer
Nivolumab has shown great promise in the treatment of kidney cancer. Following the 1st meeting to review the clinical trial evidence & cost-effectiveness of Nivolumab in treating kidney cancer, NICE has said it's unlikely they'll recommend the drug for this area. This stance needs reversing.
In 2013, more than 11,800 people were diagnosed with kidney cancer; that's about 33 people each day. It is now the seventh most common cancer in the UK: the fifth most common cancer in men and the tenth in women. Since the late 1970s, kidney cancer incidence rates have more than doubled in Great Britain. With rising numbers each year, Nivolumab could make a huge difference to many people's lives.
You can't sign this petition because it is now closed. But you can still comment on it here at Repetition.me!
3.15.235.196 Wed, 24 Apr 2024 01:16:43 +0100
